Company Profile
Formosa Laboratories provides the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers globally. It offers APIs in the areas of anticancer, vitamin D derivatives, anti-inflammatory and analgesic agents, immunomodulators, respiratory agents, cholesterol and phosphate binders, UV filter, iron deficiency anemia (IDA), CNS agents, MRI enhancing agents, steroids, antibiotics, and areas
Injectables in the areas of IDA, MRI agents, oncology, and others, as well as contract development and manufacturing services including recrystallization, filtration, dialysis, column purification, distillation, spray drying, and micronization.
Its portfolio also includes injectable manufacturing and secondary packaging, labeling, and serialization services, custom fermentation services, and peptide synthesis services. Additionally, it offers antibody-drug conjugates services comprising antibody development and manufacture.
Its portfolio also includes peptide and polymer drug conjugation, linker-payload design, synthesis, and manufacturing, bio-conjugation and purification, cytotoxic liquid-filled and lyophilized product from pre-formulation studies to manufacture, and regulatory support. It also is involved in chemical trading and investment activities. Incorporated in 1985, Formosa Laboratories is headquartered in Taoyuan City, Taiwan.